SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: per strandberg who wrote (2625)11/4/1997 8:10:00 PM
From: John Metcalf   of 6136
 
Per, do you know if this data is from the mouse and rat studies reported in April of '95? AG 3340 has since completed a Phase I study in Edinburgh in healthy volunteers. Bio-availability was demonstrated at concentrations which reduced tumors in animals. In June of 1997, AGPH received FDA clearance for a US human trial.

The results that four of six mice were tumor-free is the same data reported almost three years ago. As David S. might say, their recoveries were confirmed by autopsy.

I look forward to seeing results in humans. We've had the rodent studies for a long time.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News